Breathing Disorder Treatment Market Projected for Robust Growth Amid Rising COPD & Asthma Cases 2025 | Major key players - F. Hoffmann-La Roche, AstraZeneca, GSK plc, Abbott Laboratories.

Market Overview:

The Breathing Disorder Treatment Market is expected to grow at a CAGR of 4.8% during the forecast period 2024-2031.

The Breathing Disorder Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Breathing Disorder Treatment market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/breathing-disorder-treatment-market?sz

The Breathing Disorder Treatment Market refers to the global industry focused on diagnosing, managing, and treating respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and other breathing difficulties. It encompasses pharmaceuticals, medical devices, oxygen therapy, and surgical interventions, driven by rising respiratory disease prevalence, aging populations, environmental factors, and growing demand for advanced therapeutic solutions.

Key Developments of USA and Japan:

USA (June - September 2025):

New Drug Approvals:

Brinsupri (brensocatib): Approved by the FDA as the first-ever treatment for non-cystic fibrosis bronchiectasis (NCFB), an oral, once-daily pill for adults and adolescents (age 12+). (August 12, 2025)

Papzimeos (zopapogene imadenovec-drba): Approved by the FDA for the treatment of recurrent respiratory papillomatosis (RRP) in adults. (August 14, 2025)

Technological Advancements:

AI-powered devices: Companies like ResMed have been developing and releasing AI-powered devices and software for at-home respiratory care, focusing on personalized treatment and improved patient outcomes, particularly for conditions like COPD. (June 2025)

Advanced Imaging: The FDA cleared CT-VQ, a non-contrast, ventilation-perfusion imaging solution that utilizes a new category III CPT code for reimbursement. (September 4, 2025)

Japan (June - September 2025):

Drug Development and Regulatory Changes:

Biologic therapies: The market is seeing an increased demand for innovative treatments like biologics and combination therapies, fueled by an aging population and rising prevalence of respiratory diseases like COPD and asthma. The Japanese government is prioritizing healthcare advancements to support this.

Donidalorsen: Otsuka Pharmaceutical expanded its licensing agreement for Donidalorsen for Hereditary Angioedema to include the Asia Pacific region, including Japan. (June 18, 2025)

Key Players:

F. Hoffmann-La Roche
AstraZeneca
GSK plc
Abbott Laboratories
Amgen Inc.
Novartis AG
Medtronic plc
Dr. Reddy's Laboratories Ltd.
Bayer AG
Biogen.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=breathing-disorder-treatment-market

Market Segmentation:

By Drug Class: Antimicrobial, Corticosteroid, Bronchodilator, Antihistamines, Respiratory stimulants, Others.

By Indication: Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Pulmonary Hypertension, Lung Cancer, Allergic Rhinitis, Idiopathic Pulmonary Fibrosis, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/breathing-disorder-treatment-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Breathing Disorder Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Breathing Disorder Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Breathing Disorder Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Breathing Disorder Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Breathing Disorder Treatment Market in 2025?
◆ What is the projected growth rate of the Breathing Disorder Treatment Market through 2033?
◆ Who are the key players in the Breathing Disorder Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.